Janux Therapeutics Inc (JANX)
46.24
-1.75
(-3.65%)
USD |
NASDAQ |
May 21, 12:23
Janux Therapeutics Stock Buybacks (Quarterly): -320.51M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -320.51M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -56.53M |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.843M |
| June 30, 2021 | -205.01M |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-320.51M
Minimum
Mar 2024
0.843M
Maximum
Sep 2021
-48.43M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
| Viking Therapeutics Inc | -597.12M |
| Equillium Inc | -- |
| Minerva Neurosciences Inc | -- |
| Arvinas Inc | -- |
| Calidi Biotherapeutics Inc | -- |